Connect & Collaborate to Redefine Early-Line Oncology Patient Impact
This year’s meeting has been shaped by expert industry leaders who are facing and conquering the same challenges as you and will share their insights to help drug developers like you accelerate transformative radioligand therapies from discovery to commercialization.
Click on each to learn more.
Benchmark Against True Peers in Your Role
Pre-book 1‑2‑1 meetings with industry experts *NEW
For the first time, schedule one‑to‑one meetings via the event app to move beyond business card exchanges and connect directly with targeted companies, speakers, and peers across discovery, preclinical, translational & clinical, and CMC & supply.
Benchmark against true peers in your role
Four dedicated tracks ensure every session is tailored to your job function, allowing you to engage with global TRP peers facing the same challenges and take away more focused, technical insights.
Build end‑to‑end connections through structured networking
From speed networking to pre‑conference focus days, structured sessions enable you to build relationships across the full development lifecycle and strengthen your long‑term strategy.
Get your specific questions answered by the Scientific Advisory Board *NEW
Submit questions in advance to ensure discussions are driven by your real‑world challenges - not just high‑level industry themes.
Strengthen relationships beyond the conference room
Continue conversations during the poster session and drinks reception, creating space for deeper discussions, stronger connections, and lasting collaborations.
Explore the Agenda
Discover how leading scientists and clinicians in TRP and radioligand therapy are redefining every stage of development - from target discovery and validation to isotope selection and commercialization strategy. Gain insight into the approaches shaping the next generation of radiopharmaceutical therapies and accelerating their path to the clinic.
Partner With Us
Engage directly with key decision-makers across imaging, radiochemistry, isotope development and more, who are actively seeking collaborations. Explore opportunities to accelerate the development of safer, more effective radiopharmaceuticals and contribute to projects that move quickly from concept to clinical application.
Join TRP Experts
Network with over 260 radiochemists, biologists, clinicians, and R&D leaders who are shaping the full RLT pipeline. Share expertise, exchange ideas, and collaborate across discovery, preclinical development, and clinical translation to advance therapies that can make a real impact for patients.